Comparative Pharmacokinetics of Two Modified-Release Oral Morphine Formulations (Reliadol and Kapanol) and an Immediate-Release Morphine Tablet (Morfin ‘DAK’) in Healthy Volunteers

By Bochner F.  

Clinical Drug Investigation, Vol. 17, Iss. 1, 1999-01 ,pp. : 59-66

Adis International

Access to resources Recommend Favorite

Non-Analgesic Effects of Opioids: The Cognitive Effects of Opioids in Chronic Pain of Malignant and Non-Malignant Origin. An Update.

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6116-6122

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of opioid therapy for chronic non-malignant pain

By Marcus Dawn A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations

By >   Gibson Stephen J.  

Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. : 457-474

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite